1 min read
Add as a preferred source on Google

AbbVie Q3 Preview Centers on $3.77 Earnings Per Share Estimate

AbbVie is scheduled to report before U.S. markets open Friday, Oct. 30. Wall Street analysts expect Skyrizi and Rinvoq to drive the quarter.

An unmarked medicine vial stands beside a tablet blister pack / TokenPost.ai
An unmarked medicine vial stands beside a tablet blister pack / TokenPost.ai

AbbVie heads into Friday’s third-quarter report with a $3.77 earnings-per-share forecast, more than twice last year’s level, as Wall Street analysts expect Skyrizi and Rinvoq to boost results.

The estimate is for the quarter, not a reported result. AbbVie is scheduled to release its results before U.S. markets open Friday, Oct. 30.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…